OFFICIAL PUBLICATION OF

by its subsidiary APPco

A return to ‘pre-pandemic levels’

Sheshtyn Paola 15/07/2022

business matching - connecting puzzle elements

Shortages of intravenous and subcutaneous Actemra have been resolved as pharmacists thanked for their patience A shortage of Actemra (tocilizumab) has finally been resolved after supply was battered following recommendations last year by the World Health Organisation (WHO) for the drug to be used as a treatment for patients seriously ill COVID-19. In July last

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘Consumer confusion, pharmacist frustration’ if current system continues

I welcome Mark's move, at least someone talks about it. But like any push at the forefront, it comes with…

Benjamyn Sung

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

A return to ‘pre-pandemic levels’

Previous ‘He’s not an expert in diagnosis, he’s not an expert in management.’

Next Back on the calendar

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous ‘He’s not an expert in diagnosis, he’s not an expert in management.’

Next Back on the calendar

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.